Street View: AMD's AI ambitions take spotlight ahead of analyst day
Advanced Micro Devices AMD.O forecast fourth-quarter revenue above market estimates on Tuesday, betting on the multibillion-dollar expansions of data center infrastructure to boost demand for its artificial intelligence chips
Shares down about 4% at $240.23 premarket
QUESTIONS AROUND OPERATING LEVERAGE LINGER
Morgan Stanley ("equal weight", PT: $260) says "clearly the focus is next year's rack scale products"
J.P.Morgan ("neutral," PT: $270) says AMD continues to fire on all cylinders across its business lines, with data center again being the standout in H2'25
JPM however adds that questions around operating leverage linger
Jefferies ("buy," PT: $300) says operating expenses are a little higher but largely R&D focused and to be expected as AMD works to ramp next-gen AI and data center products with potential for more meaningful leverage in H2'26
TD Cowen ("buy," PT: $290) says "between last month's OpenAI deal, next week's Analyst Day, and a >50% 1 month rally, AMD's beat/raise is likely largely relegated to the backburner"
Adds that AMD is doing as much as could be expected to build confidence that it can grow Instinct chip sales from ~$6-7 billion currently to tens of billions in 2027 off the backs of OpenAI and other customers
Related Articles
What Drove the 'Black Tuesday' Sell-Off? Three Key Factors Behind the U.S. Stock Plunge
TradingKey - On November 4, 2025, U.S. markets suffered a sudden and sharp selloff — dubbed “Black Tuesday” — with the Nasdaq posting its largest single-day drop in a month. The rout unfolded amid growing economic and political instability, as a record-long government shutdown worsened systemic
IonQ Stock Price Skyrockets 300% in a Year, But Recently Drops 30%—Is IonQ Still a Buy?
Is IonQ worth buying? With a recent decline of nearly 30% over the past month, is now the time to buy? How much further could IonQ's stock rise?
The Tariff Refund Drama Begins: Five Major Impacts If Trump Loses the Supreme Court Case
TradingKey - A landmark legal battle with clear undertones of “small business vs. government” will unfold at the U.S. Supreme Court on November 5, a case President Donald Trump has called “the most important in American history.” The ruling will directly determine the legality of Trump’s signature
Novo Nordisk Q3 Earnings Preview: New CEO, Board Overhaul — Can the U.S. Weight-Loss Market Turn Around?
TradingKey - Novo Nordisk (NVO), one of Europe’s pharmaceutical giants and a leader in the weight-loss drug race, will report its Q3 2025 earnings before market open on November 5. Wall Street expects a modest rebound from Q2’s worst growth in four years, but significant pressure on profits remains.
Palantir Q3 2025 Earnings: Blowout Performance Can’t Hide an AI Bubble， Four Growing Risks Behind a Nearly 1,000x Valuation
TradingKey – After the close of trading on November 4, “AI application King” Palantir Technologies (PLTR) reported its third-quarter earnings for fiscal year 2025. Despite a blowout quarter, surging top-line growth, and a flood of commercial orders, the stock plunged in after-hours trading.
